Global Hepatitis B Therapeutics Market 2024-2028

Global Hepatitis B Therapeutics Market 2024-2028


The hepatitis B therapeutics market is forecasted to grow by USD 469.5 mn during 2023-2028, accelerating at a CAGR of 3.27% during the forecast period. The report on the hepatitis B therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of hepatitis B infants, growing initiatives to increase awareness about hepatitis B, and growing demand for molecular diagnostics of hbv.

Technavio's hepatitis B therapeutics market is segmented as below:

By Application
  • Drugs
  • Vaccines
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the new technological advancements as one of the prime reasons driving the hepatitis B therapeutics market growth during the next few years. Also, strong pipeline and increasing awareness and screening programs of hbv diagnostic tests will lead to sizable demand in the market.

The report on the hepatitis B therapeutics market covers the following areas:
  • Hepatitis B therapeutics market sizing
  • Hepatitis B therapeutics market forecast
  • Hepatitis B therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hepatitis B therapeutics market vendors that include Biotest AG, Bristol Myers Squibb Co., CASI Pharmaceuticals Inc., Cipla Inc., Dynavax Technologies Corp., Emergent BioSolutions Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline PLC, Hetero Healthcare Ltd., Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Sanofi SA, Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the hepatitis B therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.


1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Hepatitis B Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Hepatitis B Therapeutics Market 2018 - 2022 ($ million)
4.2 Application segment analysis 2018 - 2022
Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
6.1 Market segments
Chart on Application - Market share 2023-2028 (%)
Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
6.3 Drugs - Market size and forecast 2023-2028
Chart on Drugs - Market size and forecast 2023-2028 ($ million)
Data Table on Drugs - Market size and forecast 2023-2028 ($ million)
Chart on Drugs - Year-over-year growth 2023-2028 (%)
Data Table on Drugs - Year-over-year growth 2023-2028 (%)
6.4 Vaccines - Market size and forecast 2023-2028
Chart on Vaccines - Market size and forecast 2023-2028 ($ million)
Data Table on Vaccines - Market size and forecast 2023-2028 ($ million)
Chart on Vaccines - Year-over-year growth 2023-2028 (%)
Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 Mexico - Market size and forecast 2023-2028
Chart on Mexico - Market size and forecast 2023-2028 ($ million)
Data Table on Mexico - Market size and forecast 2023-2028 ($ million)
Chart on Mexico - Year-over-year growth 2023-2028 (%)
Data Table on Mexico - Year-over-year growth 2023-2028 (%)
8.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
8.11 Brazil - Market size and forecast 2023-2028
Chart on Brazil - Market size and forecast 2023-2028 ($ million)
Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
Chart on Brazil - Year-over-year growth 2023-2028 (%)
Data Table on Brazil - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 Biotest AG
Biotest AG - Overview
Biotest AG - Business segments
Biotest AG - Key offerings
Biotest AG - Segment focus
11.4 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
11.5 Dynavax Technologies Corp.
Dynavax Technologies Corp. - Overview
Dynavax Technologies Corp. - Product / Service
Dynavax Technologies Corp. - Key offerings
11.6 Emergent BioSolutions Inc.
Emergent BioSolutions Inc. - Overview
Emergent BioSolutions Inc. - Product / Service
Emergent BioSolutions Inc. - Key offerings
11.7 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
11.8 Gilead Sciences Inc.
Gilead Sciences Inc. - Overview
Gilead Sciences Inc. - Product / Service
Gilead Sciences Inc. - Key news
Gilead Sciences Inc. - Key offerings
11.9 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
11.10 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
11.11 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
11.12 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Company Market Positioning
Exhibits9: Parent Market
Exhibits10: Data Table on - Parent Market
Exhibits11: Market characteristics analysis
Exhibits12: Value Chain Analysis
Exhibits13: Offerings of companies included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Historic Market Size - Data Table on Global Hepatitis B Therapeutics Market 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Application - Market share 2023-2028 (%)
Exhibits31: Data Table on Application - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Drugs - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Drugs - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Drugs - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Drugs - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Vaccines - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Vaccines - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Application ($ million)
Exhibits43: Data Table on Market opportunity by Application ($ million)
Exhibits44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits45: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits46: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits47: Chart on Geographic comparison
Exhibits48: Data Table on Geographic comparison
Exhibits49: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits51: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits52: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits53: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits54: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits55: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits56: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits57: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits58: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits59: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits60: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits65: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Mexico - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Mexico - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Mexico - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Mexico - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Brazil - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Brazil - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Brazil - Year-over-year growth 2023-2028 (%)
Exhibits85: Market opportunity By Geographical Landscape ($ million)
Exhibits86: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2023 and 2028
Exhibits88: Overview on criticality of inputs and factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Companies covered
Exhibits92: Matrix on companies position and classification
Exhibits93: Biotest AG - Overview
Exhibits94: Biotest AG - Business segments
Exhibits95: Biotest AG - Key offerings
Exhibits96: Biotest AG - Segment focus
Exhibits97: Bristol Myers Squibb Co. - Overview
Exhibits98: Bristol Myers Squibb Co. - Product / Service
Exhibits99: Bristol Myers Squibb Co. - Key news
Exhibits100: Bristol Myers Squibb Co. - Key offerings
Exhibits101: Dynavax Technologies Corp. - Overview
Exhibits102: Dynavax Technologies Corp. - Product / Service
Exhibits103: Dynavax Technologies Corp. - Key offerings
Exhibits104: Emergent BioSolutions Inc. - Overview
Exhibits105: Emergent BioSolutions Inc. - Product / Service
Exhibits106: Emergent BioSolutions Inc. - Key offerings
Exhibits107: F. Hoffmann La Roche Ltd. - Overview
Exhibits108: F. Hoffmann La Roche Ltd. - Business segments
Exhibits109: F. Hoffmann La Roche Ltd. - Key news
Exhibits110: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits111: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits112: Gilead Sciences Inc. - Overview
Exhibits113: Gilead Sciences Inc. - Product / Service
Exhibits114: Gilead Sciences Inc. - Key news
Exhibits115: Gilead Sciences Inc. - Key offerings
Exhibits116: GlaxoSmithKline Plc - Overview
Exhibits117: GlaxoSmithKline Plc - Business segments
Exhibits118: GlaxoSmithKline Plc - Key news
Exhibits119: GlaxoSmithKline Plc - Key offerings
Exhibits120: GlaxoSmithKline Plc - Segment focus
Exhibits121: Merck and Co. Inc. - Overview
Exhibits122: Merck and Co. Inc. - Business segments
Exhibits123: Merck and Co. Inc. - Key news
Exhibits124: Merck and Co. Inc. - Key offerings
Exhibits125: Merck and Co. Inc. - Segment focus
Exhibits126: Novartis AG - Overview
Exhibits127: Novartis AG - Business segments
Exhibits128: Novartis AG - Key news
Exhibits129: Novartis AG - Key offerings
Exhibits130: Novartis AG - Segment focus
Exhibits131: Viatris Inc. - Overview
Exhibits132: Viatris Inc. - Business segments
Exhibits133: Viatris Inc. - Key news
Exhibits134: Viatris Inc. - Key offerings
Exhibits135: Viatris Inc. - Segment focus
Exhibits136: Inclusions checklist
Exhibits137: Exclusions checklist
Exhibits138: Currency conversion rates for US$
Exhibits139: Research methodology
Exhibits140: Information sources
Exhibits141: Data validation
Exhibits142: Validation techniques employed for market sizing
Exhibits143: Data synthesis
Exhibits144: 360 degree market analysis
Exhibits145: List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings